So… my recurrence treatment plan consists of RT and ADT & Xtandi for 2 years. I’m still working until January ’23 so cost isn’t a concern until then. My current insurance doesn’t include Xtandi in the formulary - abiraterone & Nubeqa are the covered options. An appeal is underway and coverage seems likely. But looking ahead to January when I transition to Medicare, Xtandi would cost about $12k/ yr. Nubeqa is roughly the same…but abiraterone would only be about $1.5k/yr. Once the current “anti-inflation” bill goes into effect the out of pocket limit will be $2k/yr starting in 2025.
So I’m wondering…how much better are these next generation antiandrogen medications than abiraterone?